Research Analysts’ new coverage for Friday, October 6th:

J P Morgan Chase & Co initiated coverage on shares of Abbott Laboratories (NYSE:ABT). They issued a neutral rating on the stock.

Jefferies Group LLC began coverage on shares of Alarm.com Holdings (NASDAQ:ALRM). The firm issued a hold rating on the stock.

Seaport Global Securities initiated coverage on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP). Seaport Global Securities issued a buy rating on the stock.

Seaport Global Securities began coverage on shares of AVEO Pharmaceuticals (NASDAQ:AVEO). They issued a buy rating on the stock.

Piper Jaffray Companies assumed coverage on shares of Commerce Bancshares (NASDAQ:CBSH). The firm issued a hold rating and a $60.00 price target on the stock.

Seaport Global Securities initiated coverage on shares of Conatus Pharmaceuticals (NASDAQ:CNAT). Seaport Global Securities issued a buy rating on the stock.

Seaport Global Securities assumed coverage on shares of Cytokinetics, (NASDAQ:CYTK). Seaport Global Securities issued a buy rating on the stock.

Nomura initiated coverage on shares of Caesars Entertainment Corporation (NASDAQ:CZR). The firm issued a hold rating and a $14.00 target price on the stock.

Piper Jaffray Companies initiated coverage on shares of Enterprise Financial Services Corporation (NASDAQ:EFSC). The firm issued a buy rating and a $49.00 target price on the stock.

Seaport Global Securities began coverage on shares of Evoke Pharma (NASDAQ:EVOK). The firm issued a buy rating on the stock.

Barclays PLC started coverage on shares of Keane Group (NASDAQ:FRAC). They issued a sell rating and a $16.00 price target on the stock.

Piper Jaffray Companies assumed coverage on shares of First Merchants Corporation (NASDAQ:FRME). They issued a hold rating and a $46.00 target price on the stock.

Seaport Global Securities began coverage on shares of Galectin Therapeutics (NASDAQ:GALT). The firm issued a buy rating on the stock.

Seaport Global Securities assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD). They issued a buy rating on the stock.

Seaport Global Securities began coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT). Seaport Global Securities issued a buy rating on the stock.

Nomura initiated coverage on shares of ILG (NASDAQ:ILG). Nomura issued a buy rating and a $35.00 price target on the stock.

Citigroup Inc. assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO). Citigroup Inc. issued a buy rating and a $10.00 price target on the stock.

Seaport Global Securities initiated coverage on shares of Seres Therapeutics (NASDAQ:MCRB). Seaport Global Securities issued a buy rating on the stock.

Jefferies Group LLC assumed coverage on shares of Nice Systems (NASDAQ:NICE). The firm issued a hold rating on the stock.

Seaport Global Securities initiated coverage on shares of Novavax (NASDAQ:NVAX). They issued a neutral rating on the stock.

Barclays PLC began coverage on shares of Oceaneering International (NYSE:OII). The firm issued a hold rating and a $28.00 price target on the stock.

Piper Jaffray Companies assumed coverage on shares of Old National Bancorp (NASDAQ:ONB). They issued a hold rating and a $19.00 target price on the stock.

Seaport Global Securities began coverage on shares of Pluristem Therapeutics (NASDAQ:PSTI). The firm issued a buy rating on the stock.

Seaport Global Securities started coverage on shares of Redhill Biopharma (NASDAQ:RDHL). The firm issued a buy rating on the stock.

Barclays PLC began coverage on shares of RLJ Lodging Trust (NYSE:RLJ). They issued an equal weight rating on the stock.

Seaport Global Securities began coverage on shares of Rexahn Pharmaceuticals (NYSEMKT:RNN). They issued a buy rating on the stock.

Pivotal Research began coverage on shares of Synnex Corporation (NYSE:SNX). Pivotal Research issued a hold rating on the stock.

Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.